Combination of the dipeptidyl peptidase-4 inhibitor linagliptin with insulin-based regimens in type 2 diabetes and chronic kidney disease

Janet B. McGill, Hannele Yki-Järvinen, Susanne Crowe, Hans Juergen Woerle, Maximilian Von Eynatten

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'Combination of the dipeptidyl peptidase-4 inhibitor linagliptin with insulin-based regimens in type 2 diabetes and chronic kidney disease'. Together they form a unique fingerprint.

Medicine & Life Sciences